Process development (active pharmaceutical ingredients)

A key priority of our Process Development department is to support production, ensuring smooth production flows and continuous process optimisation. Process solutions are developed to a laboratory or technical scale before being transferred to the industrial production scale.

The second equally important discipline of the department is the development of new processes for the manufacture of active protein-based pharmaceutical ingredients. As these proteins will be used in clinical trials their production must, at all times, comply with GMP requirements. Our successful work in this area is based on two things: our many years of experience in the development of production processes for biological agents and our investment in state-of-the-art technical equipment.

Protein purification is one of our main expertises

Our core competencies include the purification of highly sensitive and complex biological substances, such as enzymes (proteins), in which activity must be preserved, and their identification and comprehensive characterisation in compliance with current regulatory requirements. This applies both to organ extracts and to products obtained by fermentation.

... eukaryotic cells
... eukaryotic cells
Process development (USP)
Process development (USP)